Advisors Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Buy |
6,676
+2
| +0% | +$58 | ﹤0.01% | 1121 |
|
|
2025
Q1 | $224K | Buy |
6,674
+1,761
| +36% | +$59.1K | ﹤0.01% | 1090 |
|
|
2024
Q4 | $251K | Buy |
4,913
+2,107
| +75% | +$108K | ﹤0.01% | 1080 |
|
|
2024
Q3 | $143K | Buy |
2,806
+1,008
| +56% | +$51.5K | ﹤0.01% | 1165 |
|
|
2024
Q2 | $80.5K | Buy |
+1,798
| New | +$80.5K | ﹤0.01% | 1231 |
|